Evidence map›Paper›PMID 41249717›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

[

Shaoli Li, Xiaohui Zhang, Xiaogang Wang, Jing Wang, Meiling Xiao, Lin Chen, Hui Wang, Shumei Wei, Hong Zhang, Ying Dong

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shaoli Li *Department of Medical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
Xiaohui Zhang *Department of Nuclear Medicine and Medical PET Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Xiaogang Wang *Department of Pathology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Jing Wang *Department of Nuclear Medicine and Medical PET Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Meiling XiaoDepartment of Nuclear Medicine and Medical PET Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Lin ChenDepartment of Nuclear Medicine and Medical PET Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.
Hui WangDepartment of Pathology, Institute of Basic Medicine and Cancer (IBMC), the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
Shumei WeiDepartment of Pathology, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310058, China.
Hong ZhangDepartment of Nuclear Medicine and Medical PET Center, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China. hzhang21@zju.edu.cn.ORCID 0000-0002-4084-5150
Ying DongDepartment of Medical Oncology, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China. dongying74@zju.edu.cn.

Funding

National Outstanding Youth Science Fund Project of National Natural Science Foundation of China 32027802
6 · The paper itself

Abstract

purposeThis study aimed to investigate the prognostic value of [

methodsA total of 102 patients with high-grade STS who underwent [

resultsThe median follow-up was 38.5 months. Multivariate analysis demonstrated that SUVmax, TMTV, and lactate dehydrogenase were independent predictors of PFS (all P < 0.05), while TMTV, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, TNM stage, and Ki-67 index were independent predictors of OS (all P < 0.05). The established nomograms had signigicantly higher area under the curve than TNM stage and FNCLCC grading system (all P < 0.05). Decision curve analysis indicated that the nomograms had higher net benefits than TNM stage and FNCLCC grading system. In FNCLCC G3 group, TMTV effectively stratified patients into distinct prognostic subgroups (log-rank P < 0.05). Moreover, the expression of glutathione S-transferase π and glucose transporter 1 were significantly correlated with TMTV (both P < 0.05).

conclusionThe nomograms integrating pre-treatment [

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographySarcomaAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedNeoplasm GradingNomogramsPrognosisRetrospective StudiesTreatment OutcomeFluorodeoxyglucose F18[18F]FDG PET/CTMetabolic tumor volumePrognosisSoft tissue sarcoma

Identifiers

PMID41249717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.